Xilio Therapeutics | 4:持股變動聲明-高管 Brennan Kevin M.
Xilio Therapeutics | SC 13G:超過5%持股股東披露文件-GKCC, LLC(15.9%),Yekaterina Chudnovsky(15.9%)
Xilio Therapeutics | 3:首次持股聲明-股東 Chudnovsky Yekaterina
Xilio Therapeutics | 4:持股變動聲明-高管 Frankenfield Christopher James
Xilio Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4%),Takeda Ventures, Inc(4%)
Xilio Therapeutics | 4:持股變動聲明-董事 Bonstein Sara
Xilio Therapeutics | 4:持股變動聲明-董事 Xu Yuan
Xilio Therapeutics | 4:持股變動聲明-董事 ROSS ROBERT W.
Xilio Therapeutics | 4:持股變動聲明-董事 Rossi Christina
Xilio Therapeutics | 4:持股變動聲明-董事 Clancy Paul J
Xilio Therapeutics | 4:持股變動聲明-董事 Curran Daniel J.
Xilio Therapeutics | 4:持股變動聲明-董事 Shannon James Samuel
Xilio Therapeutics | 4:持股變動聲明-董事 Brennan Aoife
Xilio Therapeutics | 3:首次持股聲明-董事 Shannon James Samuel
Xilio Therapeutics | 3:首次持股聲明-董事 Brennan Aoife
Xilio Therapeutics | 4:持股變動聲明-高管 Russo Rene
Xilio Therapeutics | 4:持股變動聲明-高管 Frankenfield Christopher James
Xilio Therapeutics | 4:持股變動聲明-高管 Brennan Kevin M.
Xilio Therapeutics | 4:持股變動聲明-高管 Luptakova Katarina
Xilio Therapeutics | SC 13G:超過5%持股股東披露文件-Gilead Sciences, Inc.(19.9%)
暫無數據
暫無數據